Humacyte Receives U.S. Patent Covering Symvess and Other Bioengineered Tissues
Humacyte says a newly issued U.S. patent covers Symvess and other bioengineered tissues.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Humacyte says a newly issued U.S. patent covers Symvess and other bioengineered tissues.
Humacyte says a new U.S. patent covers Symvess and other bioengineered tissues.
The patent covers key aspects of how Symvess is manufactured, sterilized, stored and shipped, with coverage into 2043.
Humacyte announced issuance of a new U.S. patent covering Symvess and other bioengineered tissues.